ClinVar Miner

Submissions for variant NM_001009944.3(PKD1):c.9157G>A (p.Ala3053Thr) (rs200360336)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV001001371 SCV001158569 likely pathogenic Polycystic kidney disease, adult type 2019-06-27 criteria provided, single submitter clinical testing The PKD1 c.9157G>A; p.Ala3053Thr variant (rs200360336) is reported in the literature in several individuals affected with autosomal dominant polycystic kidney disease (Carrera 2016, Chang 2013, Wang 2019). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The alanine at codon 3053 is highly conserved, it occurs in the functionally important GPCR proteolytic cleavage site (Ponting 1999, Qian 2002), and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Based on available information, this variant is considered to be likely pathogenic. References: Carrera P et al. Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). Sci Rep. 2016 Aug 8;6:30850. Chang MY et al. Novel PKD1 and PKD2 mutations in Taiwanese patients with autosomal dominant polycystic kidney disease. J Hum Genet. 2013 Nov;58(11):720-7. Ponting CP et al. A latrophilin/CL-1-like GPS domain in polycystin-1. Curr Biol. 1999 Aug 26;9(16):R585-8. Qian F et al. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations. Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16981-6. Wang T et al. Identifying gene mutations of Chinese patients with polycystic kidney disease through targeted next-generation sequencing technology. Mol Genet Genomic Med. 2019 Jun;7(6):e720.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.